Novo Nordisk is expanding access to its drug Wegovy through a new partnership with WeightWatchers, days after cutting ties with telehealth firm Hims & Hers.
Starting July 1, WeightWatchers will collaborate with Humana’s CenterWell Pharmacy to fulfill and deliver prescriptions for Wegovy, with an aim to simplify access to the medication, according to a June 26 news release from the drugmaker.
As part of the new partnership, Novo Nordisk will launch a temporary $299 cash offer price for Wegovy from July 1-31. The offer applies to self-pay patients who are new to the company’s savings program or have not yet filled a prescription through NovoCare Pharmacy.
The move follows Novo Nordisk’s abrupt termination of its partnership with Hims & Hers, alleging the telehealth firm sold knockoff versions of Wegovy and for using deceptive marketing practices.
